Hori Hideyuki, Sato Yukihiro, Nakashima Motohiro
Department of Ophthalmology, Jichi Medical University, Japan.
Nippon Ganka Gakkai Zasshi. 2012 Feb;116(2):114-8.
Although patients with Prader-Willi syndrome have a high rate of diabetes, to date, there have been only 4 reported cases (6 eyes) undergoing vitrectomy for proliferative diabetic retinopathy. Herein, we report a case of Prader-Willi syndrome with proliferative diabetic retinopathy that was treated by early vitrectomy OU under local anesthesia.
A 30-year-old man was diagnosed as having Prader-Willi syndrome at the age of 2 years and diabetes at age 17. He was referred to our hospital as diabetic retinopathy had been detected in his first ophthalmological examination at age 29. Visual acuity was 0.6 bilaterally. Proliferative retinopathy, with cataract and macular edema, was identified in both eyes. Panretinal photocoagulation was performed on both eyes. However, proliferative membranes developed bilaterally, and vitreous hemorrhage occurred OS. Visual acuity decreased to 0.3 OU. The patient was hospitalized at our internal medicine department for blood glucose control. Subsequently, with an anesthesiologist on standby, a hypnotic sedative was injected intramuscularly, achieving retro-bulbar anesthesia. Combined cataract and vitreous surgery was performed on the left eye. One week later, a similar operation was performed on the right eye. The patient was discharged four days later. In the two years since these operation, visual acuity has been maintained at 0.8 OU.
Patients with Prader-Willi syndrome should be examined for early detection and treatment of diabetic retinopathy.
尽管普拉德-威利综合征患者糖尿病发病率很高,但迄今为止,仅有4例(6只眼)因增殖性糖尿病视网膜病变接受玻璃体切除术的报道。在此,我们报告1例患有增殖性糖尿病视网膜病变的普拉德-威利综合征患者,在局部麻醉下早期双眼玻璃体切除术治疗。
一名30岁男性在2岁时被诊断为普拉德-威利综合征,17岁时患糖尿病。29岁首次眼科检查时发现糖尿病视网膜病变,遂转诊至我院。双眼视力均为0.6。双眼均发现增殖性视网膜病变,伴有白内障和黄斑水肿。双眼均进行了全视网膜光凝。然而,双眼均出现增殖性膜,左眼发生玻璃体积血。双眼视力降至0.3。患者入住我院内科控制血糖。随后,在麻醉医生待命的情况下,肌肉注射催眠镇静剂,实现球后麻醉。左眼进行了白内障联合玻璃体手术。一周后,右眼进行了类似手术。4天后患者出院。自这些手术以来的两年里,双眼视力一直维持在0.8。
应检查普拉德-威利综合征患者,以便早期发现和治疗糖尿病视网膜病变。